{"id":"https://openalex.org/W4322012176","doi":"https://doi.org/10.1016/j.esmoop.2023.100848","title":"68P Prognosis of ovarian cancer patients with the Mexican founder mutation (a BRCA1 long genomic rearrangement) compared with other BRCA1/2 mutations","display_name":"68P Prognosis of ovarian cancer patients with the Mexican founder mutation (a BRCA1 long genomic rearrangement) compared with other BRCA1/2 mutations","publication_year":2023,"publication_date":"2023-02-01","ids":{"openalex":"https://openalex.org/W4322012176","doi":"https://doi.org/10.1016/j.esmoop.2023.100848"},"language":"en","primary_location":{"id":"doi:10.1016/j.esmoop.2023.100848","doi":"https://doi.org/10.1016/j.esmoop.2023.100848","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2023.100848","pdf_url":"http://www.esmoopen.com/article/S2059702923000686/pdf","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://www.esmoopen.com/article/S2059702923000686/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045127402","display_name":"Jose Antonio Bahena","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"J. Bahena","raw_affiliation_strings":["1Ovarian and Endometrial Cancer Program, Instituto Nacional de Cancerologia, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ovarian and Endometrial Cancer Program, Instituto Nacional de Cancerologia, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210153971"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050112856","display_name":"Edgar Montes-Serv\u00edn","orcid":"https://orcid.org/0000-0003-3746-6739","observed_orcids":["https://orcid.org/0000-0003-3746-6739"]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"E. Montes-Servin","raw_affiliation_strings":["1Ovarian and Endometrial Cancer Program, Instituto Nacional de Cancerologia, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ovarian and Endometrial Cancer Program, Instituto Nacional de Cancerologia, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210153971"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050112856","display_name":"Edgar Montes-Serv\u00edn","orcid":"https://orcid.org/0000-0003-3746-6739","observed_orcids":["https://orcid.org/0000-0003-3746-6739"]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"E. Montes-Servin","raw_affiliation_strings":["1Ovarian and Endometrial Cancer Program, Instituto Nacional de Cancerologia, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ovarian and Endometrial Cancer Program, Instituto Nacional de Cancerologia, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210153971"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077042037","display_name":"Ernesto Gonz\u00e1lez-Ibarra","orcid":"https://orcid.org/0000-0002-6326-3663","observed_orcids":["https://orcid.org/0000-0002-6326-3663"]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"E. Gonzalez-Ibarra","raw_affiliation_strings":["1Ovarian and Endometrial Cancer Program, Instituto Nacional de Cancerologia, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ovarian and Endometrial Cancer Program, Instituto Nacional de Cancerologia, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210153971"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011442693","display_name":"J. Sanchez-Flores","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"J. Sanchez-Flores","raw_affiliation_strings":["2Internal Medicine, Instituto Nacional de Cancerologia, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Internal Medicine, Instituto Nacional de Cancerologia, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210153971"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027742414","display_name":"Rosa Mar\u00eda \u00c1lvarez-G\u00f3mez","orcid":"https://orcid.org/0000-0002-5458-7201","observed_orcids":["https://orcid.org/0000-0002-5458-7201"]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"R.M. \u00c1lvarez-G\u00f3mez","raw_affiliation_strings":["3Hereditary Cancer Clinic, Instituto Nacional de Cancerologia, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Hereditary Cancer Clinic, Instituto Nacional de Cancerologia, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210153971"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012798860","display_name":"Raquel Espinosa-Romero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"R. Espinosa-Romero","raw_affiliation_strings":["1Ovarian and Endometrial Cancer Program, Instituto Nacional de Cancerologia, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ovarian and Endometrial Cancer Program, Instituto Nacional de Cancerologia, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210153971"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006305444","display_name":"Dolores Gallardo\u2010Rinc\u00f3n","orcid":"https://orcid.org/0000-0002-0628-8290","observed_orcids":["https://orcid.org/0000-0002-0628-8290"]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"D. Gallardo-Rinc\u00f3n","raw_affiliation_strings":["1Ovarian and Endometrial Cancer Program, Instituto Nacional de Cancerologia, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ovarian and Endometrial Cancer Program, Instituto Nacional de Cancerologia, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210153971"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210153971"],"apc_list":{"value":3290,"currency":"USD","value_usd":3290},"apc_paid":{"value":3290,"currency":"USD","value_usd":3290},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.01906714,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"1","first_page":"100848","last_page":"100848"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9330000281333923},{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.6869999766349792},{"id":"https://openalex.org/keywords/founder-mutation","display_name":"founder mutation","score":0.7960000038146973},{"id":"https://openalex.org/keywords/germline-brca-mutation","display_name":"germline BRCA mutation","score":0.7459999918937683},{"id":"https://openalex.org/keywords/brca2","display_name":"BRCA2","score":0.7179999947547913},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.8100000023841858},{"id":"https://openalex.org/keywords/mexican-women","display_name":"Mexican women","score":0.7300000190734863},{"id":"https://openalex.org/keywords/founder-effect","display_name":"founder effect","score":0.824999988079071}],"concepts":[{"id":"https://openalex.org/C195054827","wikidata":"https://www.wikidata.org/wiki/Q504568","display_name":"Founder effect","level":5,"score":0.7945525050163269},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6220589876174927},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.5871464610099792},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5777761936187744},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5535085797309875},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47227227687835693},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46949127316474915},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.45065850019454956},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.44986510276794434},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4362868666648865},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.43586260080337524},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2772705554962158},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2669804096221924},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.17302605509757996},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.13161051273345947},{"id":"https://openalex.org/C197754878","wikidata":"https://www.wikidata.org/wiki/Q80711","display_name":"Haplotype","level":4,"score":0.09058371186256409},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.esmoop.2023.100848","doi":"https://doi.org/10.1016/j.esmoop.2023.100848","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2023.100848","pdf_url":"http://www.esmoopen.com/article/S2059702923000686/pdf","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.esmoop.2023.100848","doi":"https://doi.org/10.1016/j.esmoop.2023.100848","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2023.100848","pdf_url":"http://www.esmoopen.com/article/S2059702923000686/pdf","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4322012176.pdf","grobid_xml":"https://content.openalex.org/works/W4322012176.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2995567055","https://openalex.org/W4296016147","https://openalex.org/W2889957256","https://openalex.org/W4281702465","https://openalex.org/W2287489874","https://openalex.org/W2065700931","https://openalex.org/W4302767450","https://openalex.org/W4317614031","https://openalex.org/W7008643684","https://openalex.org/W2144620006"],"abstract_inverted_index":{"Mexican":[0,42],"women":[1],"with":[2,34],"ovarian":[3],"cancer":[4],"have":[5],"a":[6,35,46],"high":[7],"prevalence":[8],"of":[9,20,25,61],"germline":[10],"BRCA":[11],"mutations.":[12],"The":[13,41],"most":[14],"frequent":[15],"alteration":[16],"is":[17,45],"the":[18,59],"deletion":[19],"exons":[21],"9":[22],"to":[23],"12":[24],"BRCA1":[26],"(BRCA1-Del":[27],"Exon":[28],"9-12),":[29],"which":[30],"has":[31],"been":[32],"associated":[33],"founder":[36,43],"effect":[37],"in":[38],"this":[39,64],"population.":[40],"mutation":[44],"long":[47],"genomic":[48],"rearrangement":[49],"that":[50],"could":[51],"affect":[52],"not":[53],"only":[54],"clinical":[55],"features":[56],"but":[57],"also":[58],"prognosis":[60],"patients":[62],"carrying":[63],"alteration.":[65]},"counts_by_year":[],"updated_date":"2026-09-06T09:10:53.072986","created_date":"2023-02-26T00:00:00"}